𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interrater agreement in the assessment of motor manifestations of Huntington's disease

✍ Scribed by Penelope Hogarth; Elise Kayson; Karl Kieburtz; Karen Marder; David Oakes; Diana Rosas; Ira Shoulson; Nancy S. Wexler; Anne B. Young; Hongwei Zhao


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
62 KB
Volume
20
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

With prospects improving for experimental therapeutics aimed at postponing the onset of illness in preclinical carriers of the Huntington's disease (HD) gene, we assessed agreement among experienced clinicians with respect to the motor manifestations of HD, a relevant outcome measure for preventive trials in this population. Seventy‐five clinicians experienced in the evaluation of patients with early HD and six non‐clinicians were shown a videotape compiled from the film archives of the United States–Venezuela Collaborative HD Research Project. Observers were asked to rate a 2–3‐minute segment of the motor examination for each of 17 at‐risk subjects. The rating scale ranged from 0 (normal) to 4 (unequivocal extrapyramidal movement disorder characteristic of HD). As measured by a weighted κ statistic, there was substantial agreement among the 75 clinicians in the judgment of unequivocal motor abnormalities comparing scale ratings of 4 with ratings that were not 4 (weighted κ = 0.67; standard error (SE) = 0.09). Agreement among the non‐clinicians was only fair (weighted κ = 0.28; SE = 0.10). Even under the artificial conditions of a videotape study, experienced clinicians show substantial agreement about the signs that constitute the motor manifestations of illness in subjects at risk for HD. We expect these findings to translate to a similar level of interobserver agreement in the clinical trial setting involving experienced investigators examining live patients. © 2005 Movement Disorder Society


📜 SIMILAR VOLUMES


Interrater reliability of the unified Pa
✍ Marcus Richards; Karen Marder; Lucien Cote; Dr. Richard Mayeux 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 1 views

## Abstract Interrater reliability of the Unified Parkinson's Disease Rating Scale (UPDRS) motor examination was assessed by three neurologists experienced in the administration of this scale. Intraclass correlation coefficients indicated good‐to‐excellent agreement for speeded repeated movements,

Huntington's disease: Objective assessme
✍ Ralf Reilmann; Silke Rumpf; Heike Beckmann; Raphael Koch; Erich B. Ringelstein; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

## Abstract ## Background: Postural deficits in Huntington's disease are linked to functional impairment. We investigated whether assessment of center‐of‐mass variability using posturography provides objective and quantitative measures that correlate to the severity of motor phenotype, functional

Objective assessment of motor slowness i
✍ Jeroen P.P. van Vugt; Karlijne K.E. Piet; Liesbeth J. Vink; Sabine Siesling; Aei 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract Functional disability of patients with Huntington's disease (HD) is determined by impairment of voluntary motor function rather than the presence of chorea. However, only few attempts have been made to quantify this motor impairment. By using a simple reaction time paradigm, we measured

Assessment of simple movements reflects
✍ Carsten Saft; Jürgen Andrich; Nina-Marie Meisel; Horst Przuntek; Thomas Müller 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Clinical rating, caudate atrophy, disturbed movement performance, neuropsychological testing, and age-related genetic disease load (CAG index) are tools that reflect impairment after onset of Huntington's disease (HD). Objectives were to compare scored HD symptoms, results of neuropsychological test

Assessment of coenzyme q10 tolerability
✍ Dr. A. Feigin; K. Kieburtz; P. Como; C. Hickey; D. Abwender; C. Zimmerman; K. St 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

## Abstract We performed a 6‐month open‐label trial to evaluate the tolerability and efficacy of coenzyme Q10 (CoQ) in 10 patients with Huntington's disease (HD), Subjects were evaluated at baseline, 3 months, and 6 months using the HD Rating Scale (HDRS), the HD Functional Capacity Scale (HDFCS),

Do the motor manifestations of parkinson
✍ Stacey K. Jankelowitz; David Burke 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

## Abstract Background: Axonal excitability is altered in common medical conditions such as stroke, multiple sclerosis, and spinal cord injury. Given the motor neuron changes in the presence of rigidity and tremor in Parkinson disease, we examine whether there are also changes in motor axon excitab